Ethyl 2-(6-bromoimidazo[1,2-a]pyridin-3-yl)acetate, 95.0%, 5g

(3-Fluorooxetan-3-yl)methyl 4-methylbenzenesulfonate, 95.0%, 10g

(2R,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-hydroxy-3-phenylpropanoic acid, 95+%, 500mg

4-Acryloylmorpholine (stabilized with MEHQ)>98.0%(GC)500mL

2-Ethyl-2-methyl-1,3-dioxolane>98.0%(GC)25mL

TAFLUPROST, 95%, 50mg

(S)-Tetrahydrofurfurylamine, 95.0%, 1g

Diethyl 2-(((4-bromophenyl)amino)methylene)malonate, 95.0%, 250mg

(2E)-1-(2-methoxyphenyl)-3-(5-methylfuran-2-yl)prop-2-en-1-one, 95.0%, 10g

Indolo[3,2,1-jk]carbazole>98.0%(GC)1g

2,3,4-Trimethyl-3-pentanol>98.0%(GC)5g

(2E,4E,6E,8E,10E)-4,9-Dimethyldodeca-2,4,6,8,10-pentaene-1,12-diol, 97%, 1g

1-Butyl-1-methylpyrrolidinium Hexafluorophosphate>98.0%(N)25g